Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
AOD-9604 has a short half-life of approximately 30 minutes, which means each injection creates a brief window of lipolytic activity rather than sustained fat mobilization
Because AHK-Cu and GHK-Cu share a copper-binding backbone but differ in amino acid sequence, many labs use AHK-Cu as a comparison compound when mapping which effects are copper-driven versus sequence-specific
Upstream synthesis is not anonymized through repackaging, and the on-page COA library stays accessible for review through the full procurement and audit cycle
This work was funded by: TS (Baylor College of Medicine, U01-AI24290, P01-AI152999, NINR R01-NR013497, and NIDDK P30-DK56338), SJW (NIDDK 1R41DK119052-01 and NIA P30-AG024832 [PI: E
.png.jpg)
US$ 22.43
US$ 27.57
US$ 27.21
US$ 21.25
US$ 20.52
US$ 22.82
